M&A Deal Summary

Charles River Laboratories International Acquires MPI Research

On February 13, 2018, Charles River Laboratories International acquired life science company MPI Research for 800M USD

Acquisition Highlights
  • This is Charles River Laboratories International’s 19th transaction in the Life Science sector.
  • This is Charles River Laboratories International’s 3rd largest (disclosed) transaction.
  • This is Charles River Laboratories International’s 13th transaction in the United States.
  • This is Charles River Laboratories International’s 2nd transaction in Michigan.

M&A Deal Summary

Date 2018-02-13
Target MPI Research
Sector Life Science
Buyer(s) Charles River Laboratories International
Deal Type Add-on Acquisition
Deal Value 800M USD
Advisor(s) Jefferies
SunTrust Robinson Humphrey, Inc. (Financial)
Weil Gotshal & Manges (Legal)

Target

MPI Research

Mattawan, Michigan, United States
MPI Research, Inc. is a premier non-clinical contract research organization (CRO) providing comprehensive testing services to biopharmaceutical and medical device companies worldwide. MPI Research was founded in 1995 and is based in Mattawan, Michigan.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Charles River Laboratories International

Wilmington, Massachusetts, United States

Category Company
Founded 1947
Sector Life Science
Employees20,400
Revenue 4.1B USD (2023)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.


DEAL STATS #
Overall 22 of 31
Sector (Life Science) 19 of 28
Type (Add-on Acquisition) 17 of 26
State (Michigan) 2 of 2
Country (United States) 13 of 20
Year (2018) 2 of 2
Size (of disclosed) 3 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-11 KWS BioTest

Sittingbourne, United Kingdom

KWS BioTest Ltd. is a contract research organization (CRO) specializing in in vitro and in vivo discovery testing services for immuno-oncology and inflammatory and infectious diseases. KWS BioTest was founded in 2003 and is based in Sittingbourne, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-02-13 CiToxLAB Group

Cedex, France

CiToxLAB Group is a provider of non-clinical contract research organization (CRO), specializing in regulated safety assessment services, non-regulated discovery services, and medical device testing. CiToxLAB Group was founded in 1969 and is based in Cedex, France.

Buy €448M